Latest filing published 29 May 2018 for Bellicum Pharmaceuticals, INC, €42k.
Filing timeline
BuySaleInsider track record
Alan A. Musso: trading record in brief
Alan A. Musso has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Gyre Therapeutics, Inc. and Bellicum Pharmaceuticals, Inc. The record holds 68 filings, for trades running from 13 August 2008 to 25 May 2018.
No open-market purchase appears, only 35 sales worth €3.9M. Outside the open market, there are 3 share grants and 30 option exercises. So far in 2018, the count stands at no purchases and 1 sale.
Most recently, on 29 May 2018, the filings show an open-market sale worth €42k in Bellicum Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Alan A. Musso
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,206 shares@ US$7.975.0% of flowCommon StockSEC:0001358403-18-000050:0
- 1,875 sharesCommon StockSEC:0001358403-18-000018:0
- 706 shares@ US$9.790.7% of flowCommon StockSEC:0001358403-18-000018:1
- 17,117 shares@ US$9.3316.1% of flowCommon StockSEC:0001358403-17-000171:0
- 6,206 shares@ US$9.896.1% of flowCommon StockSEC:0001358403-17-000169:0
- 6,311 shares@ US$12.248.2% of flowCommon StockSEC:0001358403-17-000079:0
- 6,273 shares@ US$20.4814.4% of flowCommon StockSEC:0001358403-16-000294:0
- 22,427 shares@ US$19.2348.2% of flowCommon StockSEC:0001358403-16-000294:1
- 600 shares@ US$19.851.3% of flowCommon StockSEC:0001358403-16-000294:2
- 29,300 shares@ US$22.34Common StockSEC:0001358403-15-000099:0
- 117,647 shares0Common StockSEC:0001209191-14-077519:0
- 55,000 shares0Common StockSEC:0001181431-14-034593:0
- 11,627 shares@ US$5.10Common StockSEC:0001140361-11-032030:0
- 2,880 shares@ US$5.63Common StockSEC:0001140361-11-032030:1
- 16,368 shares@ US$5.55Common StockSEC:0001140361-11-032030:2
- 30,875 shares@ US$21.80Common StockSEC:0001140361-11-032030:3
- 15,535 shares@ US$5.10Common StockSEC:0001140361-10-051131:0
- 15,535 shares@ US$26.61Common StockSEC:0001140361-10-051131:1
- 4,881 shares@ US$5.10Common StockSEC:0001140361-10-051131:2
- 4,881 shares@ US$26.47Common StockSEC:0001140361-10-051131:3
- 2,000 shares@ US$2.93Common StockSEC:0001140361-10-042575:0
- 2,000 shares@ US$24.65Common StockSEC:0001140361-10-042575:1
- 1,500 shares@ US$2.93Common StockSEC:0001140361-10-042575:2
- 1,500 shares@ US$24.60Common StockSEC:0001140361-10-042575:3
- 600 shares@ US$2.93Common StockSEC:0001140361-10-042286:0
25 of 65 declarations
